BRAF and melanoma: Through an initial series of experiments, we confirmed that PLX4720 had good selectivity for BRAF-mutated melanoma cell lines over those harbouring NRAS mutations and also demonstrated that PLX4720 was able to induce significant levels of apoptosis.